Can egg donor selection be improved? - A pilot study

Reproductive Biology and Endocrinology

Volumn 8, Issue , 2010, Pages

  Gleicher, Norbert ^a,b   Weghofer, Andrea ^a,c   Barad, David H ^a,d  

^a New York and Foundation for Reproductive Medicine   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; FRAGILE X MENTAL RETARDATION PROTEIN; MUELLERIAN INHIBITING FACTOR; FMR1 PROTEIN, HUMAN;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DONOR SELECTION; EGG PRODUCTION; FEMALE; GENETIC SCREENING; HETEROZYGOSITY; HUMAN; OOCYTE DONATION; OOCYTE RETRIEVAL; OVARIAN RESERVE; PILOT STUDY; TRINUCLEOTIDE REPEAT; BLOOD; CELL COUNT; CYTOLOGY; DONOR; EVALUATION; GENETICS; METHODOLOGY; OVARY; PREMATURE OVARIAN FAILURE; STANDARD; STATISTICS;

ADULT; ANTI-MULLERIAN HORMONE; CELL COUNT; DONOR SELECTION; FEMALE; FOLLICLE STIMULATING HORMONE; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; OOCYTE RETRIEVAL; OVARIAN FAILURE, PREMATURE; OVARY; PILOT PROJECTS; TISSUE DONORS; TRINUCLEOTIDE REPEAT EXPANSION; YOUNG ADULT;

EID: 77954626212     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-8-76     Document Type: Article

References (24)

1. Center for Devices and Radiological Health (CDRH), U.S. Food and Drug Administration Electronic Human Cell and Tissue Establishment Registration (eHCTERS). Updated July 5, 2007, Center for Devices and Radiological Health (CDRH), U.S. Food and Drug Administration., http://www.fda.gov/cber/tissue/tisreg.htm
2. Barad DH, Weghofer A, Gleicher N. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol 2007, 109:1404-1410.
3. Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y, Tanaka T. High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome. Hum Reprod 1995, 10:1962-1967.
4. Tummon I, Gavrilova-Jordan L, Allemand MC, Session D. Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review. Acta Obstet Gynecol Scand 2005, 84:611-616.
5. Barad DH, Weghofer A, Gleicher N. Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function. Fertil Steril 2009, 91:1553-1555. 10.1016/j.fertnstert.2008.09.069, 19217095.
6. Gnoth C, Schuring AN, Friol K, Tiggens J, Mallmann P, Godehardt E. Relevance of anti-Müllerian hormone measurement in routine IVF program. Hum Reprod 2008, 23:1359-1365. 10.1093/humrep/den108, 18387961.
7. Barad DH, Weghofer A, Goyal A, Gleicher N. Age-specific anti-Müllerian hormone (AMH): levels discriminate at each age between poorer and better oocytes yields. Fertil Steril 2009, 92(Suppl):S100-1.
8. Carlsen SM, Vanky E, Fleming R. Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome. Hum Reprod 2009, 24:1732-1738. 10.1093/humrep/dep074, 19342396.
9. Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, Mitchell P, Ambrose P, Fleming R. Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod 2009, 24:867-875. 10.1093/humrep/den480, 19136673.
10. Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil Steril 2009, 91:1700-1706. 10.1016/j.fertnstert.2008.01.098, 18384775.
11. Gleicher N, Weghofer A, Oktay K, Barad DH. The FMR1 (fragile X) gene serves as predictor of response to ovarian stimulation. Reprod Sciences 2009, 16:462-467.
12. Gleicher N, Weghofer A, Oktay K, Barad DH. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: A new infertility test?. Acta Scand Obstet Gynecol 2009, 88:1024-1030.
13. Gleicher N, Weghofer A, Barad DH. Triple CGG counts on the FMR1 (fragile X) gene vary between races/ethnicities based on distribution, but not based on normal range and median. Fertil Steril 2009, 92(Suppl):S12.
14. Gleicher N, Weghofer A, Oktay K, Barad DH. Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulation ovarian ageing. Reprod Biomed Online 2010, doi.10.1016/rbmo 2010.02.020.
15. Kevenaar ME, Meerasahib MF, Kramer P, van de Lang-Born MBN, de Jong FH, Groome NP, Themmen APN, Visser JA. Serum AMH levels reflect the size of the primordial follicle pool in mice. Endocrinology 2006, 147:3228-3224. 10.1210/en.2005-1588, 16556768.
16. Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G. Basal level of anti-Müllerian hormone is associated with oocytes quality in stimulated cycles. Hum Reprod 2006, 21:2022-2026. 10.1093/humrep/del127, 16679324.
17. Fleming R, Deshpande N, Traynor I, Yates RW. Dynamics of FSH-induced follicular gowth in subfertile women: relationship with age, insulin resistance, oocytes yield and anti-Müllerian hormone. Hum Reprod 2006, 21:1436-41. 10.1093/humrep/dei499, 16439501.
18. Sun W, Stegman BJ, Henne M, Catherino WH, Segars JH. A new approach towards ovarian reserve testing. Fertil Steril 2008, 90:2196-2203. 10.1016/j.fertnstert.2007.10.080, 2655110, 18433750.
19. Broer SL, Mol BWJ, Hendriks D, Broekmans FJM. The role of antimullerian hormone in predicting outcome after IVF: comparison with antral follicle count. Fertil Steril 2009, 91:705-715. 10.1016/j.fertnstert.2007.12.013, 18321493.
20. Knauff EA, Eijkemans MJ, Lambalk CB, ten Kate-Booji MJ, , et al. the Dutch Premature Ovarian Failue Consortium Anti-Müllerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab 2009, 94:786-792. 10.1210/jc.2008-1818, 19066296, the Dutch Premature Ovarian Failue Consortium.
21. Nelson SM, Yates RW, Fleming R. Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulation cycles-implications for individualization of therapy. Hum Reprod 2007, 22:2414-2421. 10.1093/humrep/dem204, 17636277.
22. Singer T, Barad DH, Weghofer A, Gleicher N. Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels. Fertil Steril 2009, 91:261.
23. Toner JP. Modest follicle-stimulating hormone elevations in younger women: wyarn but don't disqualify. Fertil Steril 2004, 81:1493-1495. 10.1016/j.fertnstert.2003.11.038, 15193465.
24. Fu YH, Kuhl DP, Pizutti A, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991, 67:1047-1058. 10.1016/0092-8674(91)90283-5, 1760838.